Indication
Infections and Infestations
1 clinical trial
2 products
Product
DelpazolidProduct
BedaquilineClinical trial
A Phase IIb, Open Label, Randomized Controlled Dose Ranging Multi-Center Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Exposure-Response Relationship of Different Doses of Delpazolid in Combination With Bedaquiline Delamanid Moxifloxacin in Adult Subjects With Newly Diagnosed, Uncomplicated, Smear-Positive, Drug-sensitive Pulmonary TuberculosisStatus: Completed, Estimated PCD: 2023-01-04